GAIN THERAPEUTICS, INC Increase (Decrease) in Other Current Liabilities
GAIN THERAPEUTICS, INC (GANX) reported Increase (Decrease) in Other Current Liabilities of -$50.53 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-26.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentLiabilities · last filed 2024-03-26
- GAIN THERAPEUTICS, INC increase (decrease) in other current liabilities for the quarter ending 2022-03-31 was $199.21K, a 5664.09% increase year-over-year.
- GAIN THERAPEUTICS, INC increase (decrease) in other current liabilities for the quarter ending 2021-03-31 was $3.46K.
- GAIN THERAPEUTICS, INC increase (decrease) in other current liabilities for fiscal 2023 was -$50.53K, a 107.11% decline from fiscal 2022.
- GAIN THERAPEUTICS, INC increase (decrease) in other current liabilities for fiscal 2022 was $711.07K, a 6.85% increase from fiscal 2021.
- GAIN THERAPEUTICS, INC increase (decrease) in other current liabilities for fiscal 2021 was $665.46K, a 283.05% increase from fiscal 2020.
- GAIN THERAPEUTICS, INC increase (decrease) in other current liabilities for fiscal 2020 was $173.72K.
| Period end | Increase (Decrease) in Other Current Liabilities 3 month | Increase (Decrease) in Other Current Liabilities 12 month |
|---|---|---|
| 2023-12-31 | -$50.53K 10-K · filed 2024-03-26 | |
| 2022-12-31 | $711.07K 10-K · filed 2024-03-26 | |
| 2022-03-31 | $199.21K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $665.46K 10-K · filed 2023-03-23 | |
| 2021-03-31 | $3.46K 10-Q · filed 2022-05-16 | |
| 2020-12-31 | $173.72K 10-K · filed 2022-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B |